Back to MW Marshall Wace, LLP
COAG
1 quarters
Position history for MWMarshall Wace, LLP's holdings in Hemab Therapeutics Holdings, Inc.
Yes. Marshall Wace holds 154,674 shares of COAG (Hemab Therapeutics Holdings), worth $5.7M, as of its Q2 2026 13F filing.
Current Value
$5.7M
Current Shares
154,674
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of COAG: RA Capital Management, L.P., FMR LLC, Capital International Investors, Avoro Capital Advisors LLC, JPMorgan Chase & Co.